NASDAQ:CDXS - Codexis Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$13.90 -0.20 (-1.42 %)
(As of 05/25/2018 04:00 PM ET)
Previous Close$13.90
Today's Range$13.80 - $14.25
52-Week Range$3.95 - $14.45
Volume276,272 shs
Average Volume340,971 shs
Market Capitalization$750.69 million
P/E Ratio-27.80
Dividend YieldN/A
Beta-1.71

About Codexis (NASDAQ:CDXS)

Codexis logoCodexis, Inc. discovers, develops, and sells protein catalysts. It also offers intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides protein catalyst screening and protein engineering services. In addition, it offers CodeEvolver protein engineering technology platform, which helps in developing and delivering protein catalysts that perform chemical transformations. The company's platform is used to discover novel biotherapeutic drug candidates for targeted human diseases, as well as for molecular biology and in vitro diagnostic enzymes. Its platform also enhances the pharmaceuticals companies manufacturing productivity and efficiency or outsourcing the manufacture of the intermediates and active pharmaceutical ingredients. The company sells its products to pharmaceutical manufacturers through its direct sales and business development force in the United States and Europe. Codexis, Inc. was founded in 2002 and is headquartered in Redwood City, California.

Receive CDXS News and Ratings via Email

Sign-up to receive the latest news and ratings for CDXS and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Industrial organic chemicals
Sub-IndustryBiotechnology
SectorIndustrial Products
SymbolNASDAQ:CDXS
CUSIP19200510
Phone650-421-8100

Debt

Debt-to-Equity Ratio0.02
Current Ratio1.67
Quick Ratio1.61

Price-To-Earnings

Trailing P/E Ratio-27.80
Forward P/E Ratio-51.48
P/E GrowthN/A

Sales & Book Value

Annual Sales$50.02 million
Price / Sales14.79
Cash FlowN/A
Price / CashN/A
Book Value$0.28 per share
Price / Book49.64

Profitability

EPS (Most Recent Fiscal Year)($0.50)
Net Income$-22,990,000.00
Net Margins-36.06%
Return on Equity-87.65%
Return on Assets-42.15%

Miscellaneous

Employees116
Outstanding Shares53,240,000

Codexis (NASDAQ:CDXS) Frequently Asked Questions

What is Codexis' stock symbol?

Codexis trades on the NASDAQ under the ticker symbol "CDXS."

How were Codexis' earnings last quarter?

Codexis, Inc. (NASDAQ:CDXS) released its quarterly earnings results on Thursday, May, 10th. The biotechnology company reported ($0.10) earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of ($0.08) by $0.02. The biotechnology company had revenue of $14.04 million for the quarter, compared to the consensus estimate of $13.50 million. Codexis had a negative net margin of 36.06% and a negative return on equity of 87.65%. View Codexis' Earnings History.

What price target have analysts set for CDXS?

3 analysts have issued 1-year target prices for Codexis' stock. Their predictions range from $11.00 to $16.00. On average, they expect Codexis' stock price to reach $13.00 in the next year. View Analyst Ratings for Codexis.

Who are some of Codexis' key competitors?

Who are Codexis' key executives?

Codexis' management team includes the folowing people:
  • Mr. John J. Nicols, Pres, CEO & Director (Age 54)
  • Mr. Gordon T. B. Sangster, Sr. VP & CFO (Age 65)
  • Mr. Michael D. A. Aldridge, Sr. VP of Corp. & Strategic Devel. (Age 51)
  • Dr. James J. Lalonde, Sr. VP of R&D (Age 57)
  • Mr. Achilles Antonio Clement, Director of Latin America

Has Codexis been receiving favorable news coverage?

News stories about CDXS stock have trended somewhat positive this week, Accern reports. Accern identifies positive and negative news coverage by monitoring more than 20 million news and blog sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Codexis earned a news sentiment score of 0.11 on Accern's scale. They also assigned news articles about the biotechnology company an impact score of 47.50 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the stock's share price in the immediate future.

Who are Codexis' major shareholders?

Codexis' stock is owned by a number of of retail and institutional investors. Top institutional investors include Baillie Gifford & Co. (4.33%), Prescott Group Capital Management L.L.C. (2.44%), Wells Fargo & Company MN (2.22%), Lord Abbett & CO. LLC (1.29%), First Light Asset Management LLC (1.19%) and Cortina Asset Management LLC (0.97%). Company insiders that own Codexis stock include Bernard J Kelley, David V Smith, Dennis P Wolf, Gordon Sangster, James Lalonde, John J Nicols, Michael D Aldridge, Pam P Cheng, Patrick Y Yang, Thomas R Baruch, Ventures Fund Vii LP Vivo, Ventures Vii Affiliates F Vivo and Vivo Ventures Vii, Llc. View Institutional Ownership Trends for Codexis.

Which institutional investors are selling Codexis stock?

CDXS stock was sold by a variety of institutional investors in the last quarter, including Prescott Group Capital Management L.L.C., Cortina Asset Management LLC, First Light Asset Management LLC and Blair William & Co. IL. Company insiders that have sold Codexis company stock in the last year include Bernard J Kelley, David V Smith, Dennis P Wolf, Gordon Sangster, James Lalonde, John J Nicols, Michael D Aldridge, Pam P Cheng, Thomas R Baruch and Ventures Vii Affiliates F Vivo. View Insider Buying and Selling for Codexis.

Which institutional investors are buying Codexis stock?

CDXS stock was acquired by a variety of institutional investors in the last quarter, including Lord Abbett & CO. LLC, Baillie Gifford & Co., Bradley Foster & Sargent Inc. CT, Wells Fargo & Company MN, Spark Investment Management LLC, CIBC World Markets Inc., Millennium Management LLC and Trexquant Investment LP. View Insider Buying and Selling for Codexis.

How do I buy shares of Codexis?

Shares of CDXS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Codexis' stock price today?

One share of CDXS stock can currently be purchased for approximately $13.90.

How big of a company is Codexis?

Codexis has a market capitalization of $750.69 million and generates $50.02 million in revenue each year. The biotechnology company earns $-22,990,000.00 in net income (profit) each year or ($0.50) on an earnings per share basis. Codexis employs 116 workers across the globe.

How can I contact Codexis?

Codexis' mailing address is 200 PENOBSCOT DRIVE, REDWOOD CITY CA, 94063. The biotechnology company can be reached via phone at 650-421-8100 or via email at [email protected]


MarketBeat Community Rating for Codexis (CDXS)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  171 (Vote Outperform)
Underperform Votes:  187 (Vote Underperform)
Total Votes:  358
MarketBeat's community ratings are surveys of what our community members think about Codexis and other stocks. Vote "Outperform" if you believe CDXS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CDXS will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Codexis (NASDAQ:CDXS) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
3 Wall Street analysts have issued ratings and price targets for Codexis in the last 12 months. Their average twelve-month price target is $13.00, suggesting that the stock has a possible downside of 6.47%. The high price target for CDXS is $16.00 and the low price target for CDXS is $11.00. There are currently 3 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.002.75
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $13.00$11.50$9.75$7.8125
Price Target Upside: 6.47% downside3.60% upside66.67% upside33.55% upside

Codexis (NASDAQ:CDXS) Consensus Price Target History

Price Target History for Codexis (NASDAQ:CDXS)

Codexis (NASDAQ:CDXS) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
5/16/2018StephensInitiated CoverageOverweight$16.00HighView Rating Details
3/12/2018HC WainwrightSet Price TargetBuy$12.00HighView Rating Details
10/13/2017Jefferies GroupBoost Price TargetBuy$9.00 ➝ $11.00N/AView Rating Details
1/26/2017First AnalysisDowngradeOverweight ➝ Equal Weight$5.50N/AView Rating Details
1/4/2017Ladenburg ThalmannUpgradeNeutral ➝ Buy$6.25N/AView Rating Details
(Data available from 5/26/2016 forward)

Earnings

Codexis (NASDAQ:CDXS) Earnings History and Estimates Chart

Earnings by Quarter for Codexis (NASDAQ:CDXS)

Codexis (NASDAQ:CDXS) Earnings Estimates

2018 EPS Consensus Estimate: ($0.08)
2019 EPS Consensus Estimate: $0.05
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20182($0.13)($0.05)($0.09)
Q2 20182($0.09)($0.02)($0.06)
Q3 20182($0.07)($0.02)($0.05)
Q4 20182$0.02$0.20$0.11
Q1 20191($0.07)($0.07)($0.07)
Q2 20191$0.12$0.12$0.12
Q3 20191($0.06)($0.06)($0.06)
Q4 20191$0.06$0.06$0.06

Codexis (NASDAQ CDXS) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/10/2018Q1 2018($0.0770)($0.10)$13.50 million$14.04 millionViewN/AView Earnings Details
3/8/2018Q4 2017$0.05$0.02$22.97 million$21.70 millionViewListenView Earnings Details
11/9/2017Q3 2017($0.16)($0.21)$10.00 million$9.98 millionViewN/AView Earnings Details
8/9/2017Q2 2017($0.13)($0.13)$9.61 million$10.30 millionViewListenView Earnings Details
5/9/2017Q1 2017($0.15)($0.18)$9.23 million$7.97 millionViewListenView Earnings Details
3/9/2017Q4 2016($0.11)($0.12)$9.15 million$10.00 millionViewListenView Earnings Details
11/8/2016Q3($0.14)$0.06$7.41 million$14.90 millionViewListenView Earnings Details
8/9/2016Q216$0.03$0.12$15.10 million$16.00 millionViewListenView Earnings Details
5/9/2016Q1($0.15)($0.11)$7.49 million$8.00 millionViewListenView Earnings Details
3/3/2016Q4($0.04)$0.02$11.63 million$11.60 millionViewN/AView Earnings Details
11/4/2015Q315($0.11)$0.13$8.85 million$17.40 millionViewListenView Earnings Details
8/11/2015Q215($0.14)($0.14)$7.34 million$6.02 millionViewListenView Earnings Details
5/7/2015Q115($0.12)($0.14)$8.00 million$6.80 millionViewListenView Earnings Details
3/3/2015Q414$0.01$0.07$13.30 million$14.20 millionViewListenView Earnings Details
11/4/2014Q314($0.06)($0.05)$9.00 million$7.47 millionViewListenView Earnings Details
8/6/2014Q214($0.15)($0.22)$8.50 million$6.60 millionViewListenView Earnings Details
5/7/2014Q114($0.10)($0.17)$10.00 million$7.10 millionViewListenView Earnings Details
3/11/2014Q413($0.21)($0.26)$10.00 million$9.50 millionViewListenView Earnings Details
11/12/2013Q313($0.31)($0.24)$8.50 million$3.90 millionViewListenView Earnings Details
8/9/2013Q2 2013($0.28)($0.33)$9.00 million$6.97 millionViewListenView Earnings Details
5/7/2013Q1 2013($0.36)($0.25)$7.63 million$11.48 millionViewListenView Earnings Details
2/27/2013Q4 2012($0.34)($0.41)$9.33 million$7.90 millionViewListenView Earnings Details
11/7/2012Q312($0.15)($0.06)$25.88 million$26.34 millionViewN/AView Earnings Details
8/9/2012($0.18)($0.15)ViewN/AView Earnings Details
5/10/2012($0.15)($0.21)ViewN/AView Earnings Details
2/7/2012($0.11)($0.15)ViewN/AView Earnings Details
11/1/2011($0.08)($0.08)ViewN/AView Earnings Details
7/28/2011($0.10)($0.14)ViewN/AView Earnings Details
5/5/2011($0.07)($0.10)ViewN/AView Earnings Details
2/3/2011($0.06)($0.01)ViewN/AView Earnings Details
10/28/2010Q3 2010($0.13)($0.08)ViewN/AView Earnings Details
8/5/2010Q2 2010($0.13)($0.15)ViewN/AView Earnings Details
5/26/2010Q1 2010($0.50)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Codexis (NASDAQ:CDXS) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Codexis (NASDAQ CDXS) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 11.40%
Institutional Ownership Percentage: 64.83%
Insider Trading History for Codexis (NASDAQ:CDXS)
Institutional Ownership by Quarter for Codexis (NASDAQ:CDXS)

Codexis (NASDAQ CDXS) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/24/2018Gordon SangsterCFOSell18,736$14.11$264,364.96153,189View SEC Filing  
5/21/2018Pam P ChengDirectorSell19,608$13.87$271,962.9680,356View SEC Filing  
5/17/2018Michael D AldridgeInsiderSell22,000$13.54$297,880.0022,000View SEC Filing  
5/15/2018Michael D AldridgeInsiderSell22,000$12.91$284,020.0022,000View SEC Filing  
5/14/2018James LalondeSVPSell10,000$13.09$130,900.00220,066View SEC Filing  
4/3/2018David V SmithDirectorSell6,000$10.37$62,220.00View SEC Filing  
3/29/2018Thomas R BaruchDirectorSell25,000$11.05$276,250.00184,670View SEC Filing  
3/27/2018Dennis P WolfDirectorSell41,666$11.15$464,575.90157,920View SEC Filing  
3/23/2018John J NicolsInsiderSell22,465$11.57$259,920.051,078,990View SEC Filing  
3/21/2018Bernard J KelleyDirectorSell10,206$12.22$124,717.32View SEC Filing  
9/14/2017Ventures Vii Affiliates F VivoMajor ShareholderSell1,060,000$5.78$6,126,800.00View SEC Filing  
8/21/2017Patrick Y YangDirectorBuy10,000$3.98$39,800.00348,234View SEC Filing  
11/15/2016Patrick Y YangDirectorBuy10,000$4.83$48,300.00320,340View SEC Filing  
9/8/2016Ventures Fund Vii L.P. VivoMajor ShareholderSell111,600$4.25$474,300.00View SEC Filing  
8/29/2016Dennis P WolfDirectorSell18,000$4.22$75,960.00132,360View SEC Filing  
8/24/2016Bernard J KelleyDirectorSell12,643$4.26$53,859.18234,906View SEC Filing  
8/16/2016Ventures Fund Vii L.P. VivoMajor ShareholderSell86,894$4.25$369,299.50View SEC Filing  
8/15/2016Vivo Ventures Vii, LlcMajor ShareholderSell50,000$4.27$213,500.00View SEC Filing  
8/4/2016Ventures Fund Vii L.P. VivoMajor ShareholderSell80,000$4.22$337,600.00View SEC Filing  
11/11/2015James LalondeSVPSell9,441$3.52$33,232.32168,011View SEC Filing  
9/11/2015Patrick Y YangDirectorBuy10,000$3.47$34,700.00290,246View SEC Filing  
9/10/2015Bernard J. KelleyDirectorSell5,200$3.45$17,940.00193,146View SEC Filing  
8/24/2015Patrick Y YangDirectorBuy10,000$3.84$38,400.00280,246View SEC Filing  
8/14/2015Patrick Y YangDirectorBuy20,000$3.97$79,400.00View SEC Filing  
6/15/2015Dennis P WolfDirectorSell35,416$4.10$145,205.60View SEC Filing  
11/18/2014Patrick Y YangDirectorBuy20,000$2.35$47,000.00View SEC Filing  
11/17/2014Patrick Y YangDirectorBuy20,000$2.34$46,800.00View SEC Filing  
8/12/2014Patrick Y YangDirectorBuy60,000$2.22$133,200.00View SEC Filing  
3/8/2013John J NicolsCEOBuy27,000$2.42$65,340.00View SEC Filing  
3/7/2013John J NicolsCEOBuy54,000$2.22$119,880.00View SEC Filing  
3/4/2013David D O'tooleCFOBuy10,000$2.02$20,200.00View SEC Filing  
11/12/2012David D O'tooleCFOBuy5,000$2.20$11,000.00View SEC Filing  
9/14/2012David D O'tooleCFOBuy5,000$2.78$13,900.00View SEC Filing  
9/14/2012Douglas T SheehySVPSell3,800$2.76$10,488.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Codexis (NASDAQ CDXS) News Headlines

Source:
DateHeadline
Codexis, Inc. (CDXS) CFO Sells $264,364.96 in StockCodexis, Inc. (CDXS) CFO Sells $264,364.96 in Stock
www.americanbankingnews.com - May 25 at 7:38 PM
Codexis, Inc. (CDXS) Director Pam P. Cheng Sells 19,608 SharesCodexis, Inc. (CDXS) Director Pam P. Cheng Sells 19,608 Shares
www.americanbankingnews.com - May 23 at 7:52 PM
Insider Selling: Codexis (CDXS) Insider Sells 22,000 Shares of StockInsider Selling: Codexis (CDXS) Insider Sells 22,000 Shares of Stock
www.americanbankingnews.com - May 18 at 7:53 PM
Michael D. Aldridge Sells 22,000 Shares of Codexis (CDXS) StockMichael D. Aldridge Sells 22,000 Shares of Codexis (CDXS) Stock
www.americanbankingnews.com - May 16 at 10:29 PM
Codexis (CDXS) Cut to Sell at Zacks Investment ResearchCodexis (CDXS) Cut to Sell at Zacks Investment Research
www.americanbankingnews.com - May 16 at 8:19 PM
Codexis (CDXS) Now Covered by Analysts at StephensCodexis (CDXS) Now Covered by Analysts at Stephens
www.americanbankingnews.com - May 16 at 2:28 PM
Codexis (CDXS) Given Average Recommendation of "Buy" by AnalystsCodexis (CDXS) Given Average Recommendation of "Buy" by Analysts
www.americanbankingnews.com - May 16 at 12:43 PM
Codexis (CDXS) SVP James Lalonde Sells 10,000 SharesCodexis (CDXS) SVP James Lalonde Sells 10,000 Shares
www.americanbankingnews.com - May 15 at 8:16 PM
$16.82 Million in Sales Expected for Codexis (CDXS) This Quarter$16.82 Million in Sales Expected for Codexis (CDXS) This Quarter
www.americanbankingnews.com - May 15 at 2:16 AM
-$0.04 Earnings Per Share Expected for Codexis (CDXS) This Quarter-$0.04 Earnings Per Share Expected for Codexis (CDXS) This Quarter
www.americanbankingnews.com - May 13 at 7:20 PM
Codexis (CDXS) Lowered to Hold at BidaskClubCodexis (CDXS) Lowered to Hold at BidaskClub
www.americanbankingnews.com - May 11 at 9:13 PM
Codexis (CDXS) Releases  Earnings ResultsCodexis (CDXS) Releases Earnings Results
www.americanbankingnews.com - May 11 at 4:37 PM
Codexis (CDXS) CEO John Nicols on Q1 2018 Results - Earnings Call TranscriptCodexis' (CDXS) CEO John Nicols on Q1 2018 Results - Earnings Call Transcript
seekingalpha.com - May 11 at 10:24 AM
Codexis: 1Q Earnings SnapshotCodexis: 1Q Earnings Snapshot
finance.yahoo.com - May 11 at 10:24 AM
Edited Transcript of CDXS earnings conference call or presentation 10-May-18 8:30pm GMTEdited Transcript of CDXS earnings conference call or presentation 10-May-18 8:30pm GMT
finance.yahoo.com - May 11 at 10:24 AM
Critical Review: International Flavors & Fragrances (IFF) and Codexis (CDXS)Critical Review: International Flavors & Fragrances (IFF) and Codexis (CDXS)
www.americanbankingnews.com - May 9 at 9:15 PM
Codexis (CDXS) Upgraded at Zacks Investment ResearchCodexis (CDXS) Upgraded at Zacks Investment Research
www.americanbankingnews.com - May 9 at 6:44 PM
Codexis (CDXS) Stock Rating Upgraded by ValuEngineCodexis (CDXS) Stock Rating Upgraded by ValuEngine
www.americanbankingnews.com - May 3 at 10:18 PM
Codexis to Hold First Quarter 2018 Conference Call on May 10Codexis to Hold First Quarter 2018 Conference Call on May 10
finance.yahoo.com - May 3 at 9:21 AM
Codexis (CDXS) Cut to "Buy" at BidaskClubCodexis (CDXS) Cut to "Buy" at BidaskClub
www.americanbankingnews.com - April 28 at 8:34 AM
$13.50 Million in Sales Expected for Codexis (CDXS) This Quarter$13.50 Million in Sales Expected for Codexis (CDXS) This Quarter
www.americanbankingnews.com - April 28 at 4:21 AM
 Brokerages Anticipate Codexis (CDXS) Will Post Earnings of -$0.07 Per Share Brokerages Anticipate Codexis (CDXS) Will Post Earnings of -$0.07 Per Share
www.americanbankingnews.com - April 26 at 7:46 AM
Head to Head Review: FutureFuel (FF) & Codexis (CDXS)Head to Head Review: FutureFuel (FF) & Codexis (CDXS)
www.americanbankingnews.com - April 24 at 11:04 PM
Porton Pharma Solutions and Codexis Launch Global PartnershipPorton Pharma Solutions and Codexis Launch Global Partnership
finance.yahoo.com - April 23 at 9:11 AM
Codexis (CDXS) Upgraded at BidaskClubCodexis (CDXS) Upgraded at BidaskClub
www.americanbankingnews.com - April 18 at 12:16 PM
Codexis (CDXS) to Post Q2 2018 Earnings of ($0.09) Per Share, Jefferies Group ForecastsCodexis (CDXS) to Post Q2 2018 Earnings of ($0.09) Per Share, Jefferies Group Forecasts
www.americanbankingnews.com - April 18 at 8:05 AM
Brokers Offer Predictions for Codexis Q1 2019 Earnings (CDXS)Brokers Offer Predictions for Codexis' Q1 2019 Earnings (CDXS)
www.americanbankingnews.com - April 17 at 6:51 AM
Codexis (CDXS) Presents At H. C. Wainwright Global Life Sciences Conference - SlideshowCodexis (CDXS) Presents At H. C. Wainwright Global Life Sciences Conference - Slideshow
seekingalpha.com - April 11 at 4:28 PM
 Brokerages Expect Codexis (CDXS) to Post -$0.07 Earnings Per Share Brokerages Expect Codexis (CDXS) to Post -$0.07 Earnings Per Share
www.americanbankingnews.com - April 9 at 9:14 AM
Contrasting Codexis (CDXS) & Sensient Technologies (SXT)Contrasting Codexis (CDXS) & Sensient Technologies (SXT)
www.americanbankingnews.com - April 8 at 1:30 AM
Why Codexis, Inc. Stock Is Tumbling TodayWhy Codexis, Inc. Stock Is Tumbling Today
finance.yahoo.com - April 6 at 4:39 PM
After-Hours Stock Movers 04/05: (GCAP) (OGEN) (PSMT) Higher; (CDXS) (ETH) (ORBC) Lower (more...)After-Hours Stock Movers 04/05: (GCAP) (OGEN) (PSMT) Higher; (CDXS) (ETH) (ORBC) Lower (more...)
www.streetinsider.com - April 6 at 9:56 AM
Codexis prices stock offering at $9.25; shares down 10% premarketCodexis prices stock offering at $9.25; shares down 10% premarket
seekingalpha.com - April 6 at 6:42 AM
Equities Analysts Offer Predictions for Codexis Q1 2018 Earnings (CDXS)Equities Analysts Offer Predictions for Codexis' Q1 2018 Earnings (CDXS)
www.americanbankingnews.com - April 6 at 6:39 AM
Codexis Announces Pricing of Public Offering of Common StockCodexis Announces Pricing of Public Offering of Common Stock
feeds.benzinga.com - April 5 at 10:06 PM
Codexis Announces Proposed Public Offering of Common StockCodexis Announces Proposed Public Offering of Common Stock
finance.yahoo.com - April 5 at 4:26 PM
Codexis (CDXS) Director Sells $62,220.00 in StockCodexis (CDXS) Director Sells $62,220.00 in Stock
www.americanbankingnews.com - April 5 at 1:23 PM
Codexis to Present at H.C. Wainwright Global Life Sciences Conference in Monte Carlo, MonacoCodexis to Present at H.C. Wainwright Global Life Sciences Conference in Monte Carlo, Monaco
finance.yahoo.com - April 5 at 9:00 AM
Codexis Forecasted to Earn Q3 2018 Earnings of ($0.02) Per Share (CDXS)Codexis Forecasted to Earn Q3 2018 Earnings of ($0.02) Per Share (CDXS)
www.americanbankingnews.com - April 5 at 8:41 AM
Codexis (CDXS) Upgraded to "Buy" by ValuEngineCodexis (CDXS) Upgraded to "Buy" by ValuEngine
www.americanbankingnews.com - April 3 at 5:52 PM
Codexis (CDXS) Cut to Hold at BidaskClubCodexis (CDXS) Cut to Hold at BidaskClub
www.americanbankingnews.com - March 30 at 6:14 PM
Edited Transcript of CDXS earnings conference call or presentation 8-Mar-18 9:30pm GMTEdited Transcript of CDXS earnings conference call or presentation 8-Mar-18 9:30pm GMT
finance.yahoo.com - March 30 at 4:29 PM
Codexis, Inc. (CDXS) Director Thomas R. Baruch Sells 25,000 SharesCodexis, Inc. (CDXS) Director Thomas R. Baruch Sells 25,000 Shares
www.americanbankingnews.com - March 30 at 1:14 PM
Codexis (CDXS) Lifted to "Buy" at BidaskClubCodexis (CDXS) Lifted to "Buy" at BidaskClub
www.americanbankingnews.com - March 28 at 6:32 PM
Insider Selling: Codexis, Inc. (CDXS) Director Sells 41,666 Shares of StockInsider Selling: Codexis, Inc. (CDXS) Director Sells 41,666 Shares of Stock
www.americanbankingnews.com - March 28 at 1:16 PM
$13.50 Million in Sales Expected for Codexis, Inc. (CDXS) This Quarter$13.50 Million in Sales Expected for Codexis, Inc. (CDXS) This Quarter
www.americanbankingnews.com - March 25 at 7:15 AM
Insider Selling: Codexis, Inc. (CDXS) Insider Sells 22,465 Shares of StockInsider Selling: Codexis, Inc. (CDXS) Insider Sells 22,465 Shares of Stock
www.americanbankingnews.com - March 23 at 10:14 PM
Zacks: Brokerages Anticipate Codexis, Inc. (CDXS) Will Post Earnings of -$0.12 Per ShareZacks: Brokerages Anticipate Codexis, Inc. (CDXS) Will Post Earnings of -$0.12 Per Share
www.americanbankingnews.com - March 23 at 9:30 AM
Bernard J. Kelley Sells 10,206 Shares of Codexis, Inc. (CDXS) StockBernard J. Kelley Sells 10,206 Shares of Codexis, Inc. (CDXS) Stock
www.americanbankingnews.com - March 22 at 7:32 PM
Codexis (CDXS) Rating Lowered to Sell at Zacks Investment ResearchCodexis (CDXS) Rating Lowered to Sell at Zacks Investment Research
www.americanbankingnews.com - March 14 at 7:17 PM

SEC Filings

Codexis (NASDAQ:CDXS) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Codexis (NASDAQ:CDXS) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Codexis (NASDAQ CDXS) Stock Chart for Saturday, May, 26, 2018

Loading chart…

This page was last updated on 5/26/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.